EcoDrugPlus

Ensembl ID : ENSEEEG00000010895
Gene Symbol: -
Cross references: -
306 Possible Orthologues:

Ensembl ID : ENSEEEG00000013419
Gene Symbol: -
Cross references: -
207 Possible Orthologues:

Ensembl ID : ENSEEEG00000003192
Gene Symbol: -
Cross references: -
620 Possible Orthologues:

Ensembl ID : ENSEEEG00000006661
Gene Symbol: -
Cross references: -
167 Possible Orthologues:

Ensembl ID : ENSEEEG00000007175
Gene Symbol: -
Cross references: -
141 Possible Orthologues:

Ensembl ID : ENSEEEG00000007192
Gene Symbol: -
Cross references: -
211 Possible Orthologues:

Ensembl ID : ENSEEEG00000013437
Gene Symbol: -
Cross references: -
205 Possible Orthologues:

Ensembl ID : ENSEEEG00000021492
Gene Symbol: -
Cross references: -
186 Possible Orthologues:

Ensembl ID : ENSEEEG00000007193
Gene Symbol: -
Cross references: -
211 Possible Orthologues:

Ensembl ID : ENSEEEG00000015459
Gene Symbol: -
1 Cross references
191 Possible Orthologues:

Ensembl ID : ENSEEEG00000018132
Gene Symbol: -
1 Cross references
207 Possible Orthologues:

Ensembl ID : ENSEEEG00000008016
Gene Symbol: -
Cross references: -
165 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).